Buy Incyte Genomics, Inc. (INCY) and Pharmacyclics (PCYC) Into ASCO Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Baird Bullish on Pharmacyclics (PCYC) Following ASCO Abstracts
May 15, 2014 7:01 AM EDTBaird analyst Brian Skorney reiterated an Outperform rating and $173 price target on Pharmacyclics (NASDAQ: PCYC) saying the ASCO abstracts firms up IImbruvica's competitive profile.
Skorney comments, "We believe concerns over the competitive landscape in CLL will be kept in check following last night's... More
